Dr. Carl Joshua Danzig , MD
Ophthalmology โข Plantation, FL
850 S Pine Island Rd Ste A100
Plantation, FL 333243118
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 16, 2008; this date does not establish years in practice.
-
Published CMS data list 14,174 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2777 โ Injection, faricimab-svoa, 0.1 mg: 6,240 service units.
- 92134 โ Imaging of retina: 2,171 service units.
- 67028 โ Injection of drug into eye: 1,119 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 15 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 1,741 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Vabysmo (Faricimab-Svoa) โ 452 prescription fills, including refills.
- Latanoprost โ 253 prescription fills, including refills.
- Eylea (Aflibercept) โ 167 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 23 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Ophthalmology in Plantation, FL (2024, 16 clinicians with data). Median for this group: 1,534. Middle half: 703 to 3,440.
More Medicare Part B services than 90% of clinicians listed under Ophthalmology in Florida (2024, 1,013 clinicians with data). Median for this group: 2,189. Middle half: 818 to 4,724.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 9,195 in 2020 to 14,174 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
850 S Pine Island Rd Ste A100
Plantation, FL 333243118
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Bonita Springs, FL. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 2 distinct group names: Advanced Retina Institute Llc; William J Rand Mdpa. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Temple University School Of Medicine
2004
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,046 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $937,192 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $719,121 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
2,295 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,620,593 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $150,110.30 across 150 records.
By nature of payment (3 largest of 4)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $78,900.00 across 13 records.
- Consulting Fee: $57,347.91 across 49 records.
- Travel and Lodging: $9,636.96 across 27 records.
Reporting-company totals (3 largest of 13)
- Astellas Pharma US Inc: $91,955.04 across 61 records.
- Ocular Therapeutix, Inc.: $36,074.92 across 46 records.
- Genentech, Inc.: $9,196.41 across 11 records.
Research and ownership records are not included in these totals; they are in the table below.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
22 years (graduated 2004)
CMS Doctors and Clinicians data list 2004 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2008
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Danzig has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Danzig as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Plantation and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Ophthalmology in Plantation, FL (2024, 16 clinicians with data). Median for this group: 1,534. Middle half: 703 to 3,440.
More Medicare Part B services than 90% of clinicians listed under Ophthalmology in Florida (2024, 1,013 clinicians with data). Median for this group: 2,189. Middle half: 818 to 4,724.
Medicare-allowed amount
A higher Medicare-allowed amount than 90% of clinicians listed under Ophthalmology in Plantation, FL (2024, 16 clinicians with data). Median for this group: $156,109. Middle half: $61,545 to $421,363.
A higher Medicare-allowed amount than 85% of clinicians listed under Ophthalmology in Florida (2024, 1,013 clinicians with data). Median for this group: $242,390. Middle half: $87,419 to $538,035.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Ophthalmology in Plantation, FL (2024, 16 clinicians with data). Median for this group: $112,462. Middle half: $42,548 to $314,567.
A higher Medicare payment amount than 85% of clinicians listed under Ophthalmology in Florida (2024, 1,013 clinicians with data). Median for this group: $175,695. Middle half: $62,701 to $392,398.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Ophthalmology in Plantation, FL (2024, 18 clinicians with data). Median for this group: 2,066. Middle half: 698 to 3,432.
More Part D prescriptions than 60% of clinicians listed under Ophthalmology in Florida (2024, 1,100 clinicians with data). Median for this group: 1,203. Middle half: 441 to 2,500.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Ophthalmology in Plantation, FL (2024, 18 clinicians with data). Median for this group: $220,487. Middle half: $45,841 to $400,746.
A higher Part D drug cost than 95% of clinicians listed under Ophthalmology in Florida (2024, 1,100 clinicians with data). Median for this group: $114,994. Middle half: $23,881 to $309,393.
24 active clinicians are listed under Ophthalmology with a practice address in Plantation, FL (1,584 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Plantation
4.2% of these 24 clinicians have the CMS telehealth indicator.
70.8% of these 24 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 54% from 9,195 in 2020 to 14,174 in 2024.
- 2020: 9,195
- 2021: 9,551
- 2022: 10,601
- 2023: 13,606
- 2024: 14,174
-
Medicare-allowed amount
Medicare-allowed amount decreased 46% from $1,749,686 in 2020 to $937,192 in 2024.
- 2020: $1,749,686
- 2021: $1,904,760
- 2022: $1,682,872
- 2023: $1,096,142
- 2024: $937,192
-
Paid by Medicare
Paid by Medicare decreased 47% from $1,361,923 in 2020 to $719,121 in 2024.
- 2020: $1,361,923
- 2021: $1,491,747
- 2022: $1,304,760
- 2023: $834,750
- 2024: $719,121
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 122% from 786 in 2020 to 1,741 in 2024.
- 2020: 786
- 2021: 967
- 2022: 1,345
- 2023: 1,228
- 2024: 1,741
-
30-day fills
30-day fills increased 103% from 1,132 in 2020 to 2,295 in 2024.
- 2020: 1,132
- 2021: 1,365
- 2022: 1,826
- 2023: 1,840
- 2024: 2,295
-
Part D drug cost
Part D drug cost increased 414% from $510,160 in 2020 to $2,620,593 in 2024.
- 2020: $510,160
- 2021: $659,521
- 2022: $1,881,860
- 2023: $1,712,701
- 2024: $2,620,593
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 402% from $32,323.80 in 2021 to $162,369.72 in 2025.
- 2021: $32,323.80
- 2022: $44,646.58
- 2023: $62,518.88
- 2024: $147,827.85
- 2025: $162,369.72
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 155 records totaling $162,369.72.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Ocular Therapeutix, Inc. |
General
Cash or cash equivalent
|
โ | Research | $9,600.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Izervay | General | $8,400.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Izervay | General | $8,400.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Izervay | General | $8,400.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Izervay | General | $8,400.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Izervay | General | $8,400.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Izervay | General | $8,400.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Izervay | General | $7,200.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Izervay | General | $7,200.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Izervay | General | $6,000.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Izervay | General | $5,200.00 |
| Genentech, Inc. |
Consulting Fee
Cash or cash equivalent
|
Vabysmo | General | $4,275.00 |
| Genentech, Inc. |
Consulting Fee
Cash or cash equivalent
|
โ | General | $3,445.00 |
| Apellis Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
โ | General | $2,838.00 |
| Astellas Pharma Global Development |
Consulting Fee
Cash or cash equivalent
|
Izervay | General | $2,769.00 |
| Astellas Pharma US Inc |
Consulting Fee
Cash or cash equivalent
|
Izervay | General | $2,600.00 |
| Ocular Therapeutix, Inc. |
Consulting Fee
Cash or cash equivalent
|
โ | General | $2,500.00 |
| Ocular Therapeutix, Inc. |
Consulting Fee
Cash or cash equivalent
|
โ | General | $2,500.00 |
| Ocular Therapeutix, Inc. |
Consulting Fee
Cash or cash equivalent
|
โ | General | $2,000.00 |
| Ocular Therapeutix, Inc. |
Consulting Fee
Cash or cash equivalent
|
โ | General | $2,000.00 |
| Ocular Therapeutix, Inc. |
Consulting Fee
Cash or cash equivalent
|
โ | General | $2,000.00 |
| Astellas Pharma Global Development |
Consulting Fee
Cash or cash equivalent
|
Izervay | General | $1,846.00 |
| Ocular Therapeutix, Inc. |
Consulting Fee
Cash or cash equivalent
|
โ | General | $1,833.33 |
| Ocular Therapeutix, Inc. |
Consulting Fee
Cash or cash equivalent
|
โ | General | $1,500.00 |
| Astellas Pharma US Inc |
Travel and Lodging
Cash or cash equivalent
|
Izervay | General | $1,452.87 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2777
Injection, faricimab-svoa, 0.1 mg
|
6,240 | 54 | $58.33 | $34.21 |
|
92134
Imaging of retina
|
2,171 | 971 | $100.00 | $41.88 |
|
67028
Injection of drug into eye
|
1,119 | 262 | $250.63 | $132.38 |
|
92250
Photography of the retina
|
938 | 778 | $120.00 | $38.92 |
|
92012
Established patient problem focused exam of visual system
|
840 | 381 | $150.00 | $92.02 |
|
J3490
Unclassified drugs
|
837 | 226 | $234.77 | $104.01 |
|
92014
Established patient complete exam of visual system
|
796 | 707 | $449.70 | $131.13 |
|
J2782
Injection, avacincaptad pegol, 0.1 mg
|
660 | 12 | $175.00 | $108.40 |
|
J0177
Injection, aflibercept hd, 1 mg
|
248 | 15 | $437.50 | $329.44 |
|
92004
New patient complete exam of visual system
|
102 | 102 | $450.00 | $154.27 |
|
92201
Extended exam of the back part of the eye with retinal drawing
|
67 | 52 | $80.00 | $26.12 |
|
92202
Extended exam of the back part of the eye with optic nerve drawing
|
61 | 61 | $80.00 | $15.90 |
|
92083
Exam of visual field with extended testing
|
45 | 43 | $100.00 | $64.99 |
|
76512
2d ultrasound scan of eye tissue and structures
|
32 | 27 | $175.00 | $55.21 |
|
92235
Exam of retinal blood vessels using a special camera after injection of a dye
|
18 | 16 | $250.00 | $168.62 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Vabysmo | Faricimab-Svoa | 452 | 13,866 | $1,401,328.31 | 92 |
| Latanoprost | Latanoprost | 253 | 11,238 | $2,104.63 | 78 |
| Eylea | Aflibercept | 167 | 5,646 | $451,933.41 | 49 |
| Brimonidine Tartrate | Brimonidine Tartrate | 116 | 4,640 | $2,800.55 | 33 |
| Izervay | Avacincaptad Pegol Sodium/Pf | 100 | 2,854 | $240,940.88 | 16 |
| Eylea Hd | Aflibercept | 99 | 4,186 | $402,635.03 | 28 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 86 | 1,690 | $2,159.98 | 31 |
| Prednisolone Acetate | Prednisolone Acetate | 85 | 2,068 | $3,196.26 | 43 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 75 | 4,588 | $1,144.32 | 29 |
| Dorzolamide Hcl | Dorzolamide Hcl | 41 | 2,301 | $572.48 | 16 |
| Ofloxacin | Ofloxacin | 37 | 707 | $405.18 | 30 |
| Combigan | Brimonidine Tartrate/Timolol | 32 | 1,365 | $10,704.48 | โ |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 32 | 1,335 | $12,182.87 | โ |
| Difluprednate | Difluprednate | 23 | 342 | $2,202.12 | โ |
| Prolensa | Bromfenac Sodium | 21 | 959 | $8,142.06 | โ |
| Timolol Maleate | Timolol Maleate | 20 | 913 | $171.86 | โ |
| Lucentis | Ranibizumab | 19 | 760 | $40,580.01 | โ |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 17 | 220 | $206.82 | 14 |
| Restasis | Cyclosporine | 16 | 600 | $11,739.54 | โ |
| Fluorometholone | Fluorometholone | 14 | 787 | $1,319.37 | โ |
| Alphagan P | Brimonidine Tartrate | 13 | 756 | $5,360.03 | โ |
| Simbrinza | Brinzolamide/Brimonidine Tart | 12 | 570 | $2,375.94 | โ |
| Ozurdex | Dexamethasone | 11 | 694 | $16,386.63 | โ |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-10-20NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
NUCC Taxonomy Code: 207WX0107X
An ophthalmologist who specializes in the diagnosis and treatment of vitreoretinal diseases.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20111011000305
FL
8820148711
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Advanced Retina Institute Llc
28901 Trails Edge Blvd, Bonita Springs, FL 341347588
Phone: 2395443122
William J Rand Mdpa
5 W Sample Rd, Pompano Beach, FL 330643542
Phone: 9547821700
Secondary Practice Locations
28901 Trails Edge Blvd Ste 202
Bonita Springs, FL 341347588
Phone: 2395443122
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Ophthalmology - Retina Specialist
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Advanced Practice Registered Nurse
Ophthalmology - Ophthalmic Plastic and Reconstructive Surgery
Doctor of Medicine (M.D.)
Ophthalmology - Ophthalmic Plastic and Reconstructive Surgery
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Specialist
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 850 S PINE ISLAND RD STE A100, PLANTATION, FL 333243118 (Tel: 9547415555)
Registered at 850 S PINE ISLAND RD STE A100, PLANTATION, FL 333243118 (Tel: 9547415555)
Additional practice office at 28901 Trails Edge Blvd Ste 202, Bonita Springs, FL 341347588
Registered at 28901 TRAILS EDGE BLVD STE 202, BONITA SPRINGS, FL 341347588 (Tel: 2395443122)
Registered at 28901 TRAILS EDGE BLVD STE 202, BONITA SPRINGS, FL 341347588 (Tel: 2156305010)
Registered at 5 W SAMPLE RD, POMPANO BEACH, FL 33064 (Tel: 9547821700)
Registered at 5 W SAMPLE RD, POMPANO BEACH, FL 330643542 (Tel: 2156305010)
Ophthalmology (license number reported to NPPES: FL ME109536)
NPI status registered as active in NPPES database
Registered at 5323 HARRY HINES BLVD, DALLAS, TX 753909057 (Tel: 2156305010)
Registered at 2419 ELLIS ST, APT. 661, DALLAS, TX 752042498 (Tel: 2156305010)
Recorded as CARL DANZIG, M.D.
Ophthalmology (license number reported to NPPES: TX N2461)
NPI status registered as active in NPPES database
Registered at 5323 HARRY HINES BLVD, DALLAS, TX 753909057 (Tel: 2156305010)
Registered at 2419 ELLIS ST, APT. 661, DALLAS, TX 752042498 (Tel: 2156305010)
Recorded as CARL DANZIG, M.D.
Ophthalmology (license number reported to NPPES: TX N2461)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Plantation
- Dr. Alec Chaleff, MD
- Gabriela Rifkin
- Dr. Geetha Vedula, MD
- Hamza Bhalli
- Dr. Elena Bitrian, MD
- Dr. Lee Klein, MD
Mailing Address
850 S Pine Island Rd Ste A100
Plantation, FL 333243118
Phone: 9547415555